What is the Global market size of the Recombinant Protein Market?

Global Recombinant Protein Market size was valued at USD 1.75 billion in 2021 and is poised to grow from USD 1.96 billion in 2022 to USD 4.18 billion by 2030, growing at a CAGR of 12% in the forecast period (2023-2030).

What is the key driver of the Global Recombinant Protein Market?

The market has seen a consistent increase in R&D expenditure and funding in pharmaceutical and biotechnological firms throughout the period. The number of regulatory requirements has increased dramatically in recent years, expanding a lot of choices to those with unusual illnesses like hemophilia and other bleeding disorders.

Global Recombinant Protein Market Size, Share, Growth Analysis, By Product Type(Hormone, Enzymes), By Application(Research, Therapeutics) - Industry Forecast 2024-2031

Report ID: SQMIG35H2039 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 66 | Figures: 75

Global Recombinant Protein Market Competitive Landscape

Recombinant Protein Market Top Players Company Profiles

Thermo Fisher Scientific Inc.
Merck KGaA (EMD Millipore)
Novartis International AG
AbbVie Inc.
Amgen Inc.
Roche Holding AG
Pfizer Inc.
Johnson & Johnson
Sanofi S.A.
Biogen Inc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Gilead Sciences Inc.
Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
Genentech Inc. (a subsidiary of Roche Holding AG)
Regeneron Pharmaceuticals Inc.
AstraZeneca plc
GlaxoSmithKline plc
Bio-Rad Laboratories Inc.
Qiagen N.V.

Recombinant Protein Market Recent Development

In September 2021, Aviva Systems Biology, a global key player in producing antibodies, ELISA tests kits, and recombinant proteins for scientific research, confirmed the introduction of its new protein on demand semi-custom recombinant protein portfolio for basic research and pre-clinical investigations.

Global Recombinant Protein Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Recombinant Protein Market size was valued at USD 1.75 billion in 2019 and is poised to grow from USD 1.96 billion in 2023 to USD 4.18 billion by 2031, growing at a CAGR of 12% in the forecast period (2024-2031).

There are several dominant players in the recombinant protein business. Several strategic activities, such as mergers, partnerships, alliances, new product launches, acquisitions, and collaborations, are being implemented by the firms to help them increase their international competitiveness. For instance, in February 2021, In order to determine the best antigen dosages for the Phase 3 evaluation of its adjuvanted recombinant protein COVID-19 vaccine candidates, Sanofi and GSK have begun a new Phase 2b trial with 720 individuals who are 18 years old & older. 'Thermo Fisher Scientific Inc.', 'Merck KGaA (EMD Millipore)', 'Novartis International AG', 'AbbVie Inc.', 'Amgen Inc.', 'Roche Holding AG', 'Pfizer Inc.', 'Johnson & Johnson', 'Sanofi S.A.', 'Biogen Inc.', 'Eli Lilly and Company', 'Bristol-Myers Squibb Company', 'Gilead Sciences Inc.', 'Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)', 'Genentech Inc. (a subsidiary of Roche Holding AG)', 'Regeneron Pharmaceuticals Inc.', 'AstraZeneca plc', 'GlaxoSmithKline plc', 'Bio-Rad Laboratories Inc.', 'Qiagen N.V.'

Over the projected time frame, the antibody segment is projected to expand at an exponential rate. This process has attracted attention in recent years and several businesses have embraced it for use in a variety of applications. After a selection procedure for antibodies with the necessary qualities, the genes can be introduced into an expression system, and the antibodies can be generated in large amounts.

In 2022, North America accounted for the largest share of the global market, and this trend is expected to continue during the forecast. The rising prevalence of chronic diseases, growing R&D investments, increased research and government incentives, and the presence of manufacturing companies in the U.S. are all factors contributing to North America’s market development.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Recombinant Protein Market Size, Share, Growth Analysis, By Product Type(Hormone, Enzymes), By Application(Research, Therapeutics) - Industry Forecast 2024-2031

Global Recombinant Protein Market Competitive Landscape

Global Recombinant Protein Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Recombinant Protein Market?

Who are the key vendors in the Global Recombinant Protein Market?

What is the key driver of Global Recombinant Protein Market?

What is the key market trend for Global Recombinant Protein Market?

Which region accounted for the largest share in Global Recombinant Protein Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300